227 results on '"Ross, Paul J"'
Search Results
2. Supplementary Table S9 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
3. Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data
4. Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
5. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
6. Mixed Hepatocellular/Cholangiocarcinomas: Current Perspectives and Management
7. Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
8. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
9. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
10. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
11. Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial
12. Mixed Hepatocellular/Cholangiocarcinomas: Current Perspectives and Management
13. A phase I/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC).
14. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
15. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
16. A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL.
17. Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208.
18. The Greater Risk of Fewer Deaths: An Ethnodemographic Approach to Child Mortality in Hausaland
19. LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
20. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply
21. Phase III study of NUC-1031 + cisplatin versus gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
22. Impact of the COVID-19 pandemic in treating gastrointestinal (GI) cancer patients receiving systemic anticancer treatment (SACT): The Guy's Cancer Centre experience.
23. Cost–utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma
24. COVID-19 infection in gastrointestinal (GI) cancer patients receiving systemic anticancer treatment (SACT) during the outbreak of the pandemic: The Guy's Cancer Centre experience.
25. NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)
26. Su1146 PANCO: AN OPEN-LABEL, SINGLE-ARM PILOT STUDY OF PHOSPHORUS-32 (ONCOSIL™) MICROPARTICLES IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA (LAPC) IN COMBINATION WITH FOLFIRINOX OR GEMCITABINE + NAB-PACLITAXEL (GNP) CHEMOTHERAPIES
27. NUC-1031 in combination with cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
28. Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study.
29. Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study
30. FOLFOX as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
31. Chemotherapy of oesophago-gastric cancer
32. Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study
33. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
34. Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: a multicenter UK study
35. Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer
36. Phase III Study of Mitomycin-C with Protracted Venous Infusion or Circadian-Timed Infusion of 5-Fluorouracil in Advanced Colorectal Carcinoma
37. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma : A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
38. A Randomized Trial Comparing Defined-Duration With Continuous Irinotecan Until Disease Progression in Fluoropyrimidine and Thymidylate Synthase Inhibitor–Resistant Advanced Colorectal Cancer
39. Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
40. The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer
41. Impact of 5-Fluorouracil Rechallenge on Subsequent Response and Survival in Advanced Colorectal Cancer: Pooled Analysis from Three Consecutive Randomized Controlled Trials
42. Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkinʼs and non-Hodgkinʼs lymphoma
43. Epirubicin, Cisplatin, and Protracted Venous-Infusion Fluorouracil in Advanced Esophagogastric Cancer
44. Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials
45. ECF in Gastric Cancer
46. The indigenization of pharmaceuticals: therapeutic transitions in rural Hausaland
47. PanCO: An open-label, single-arm pilot study of phosphorus-32 (P-32; Oncosil) microparticles in patients with unresectable locally advanced pancreatic adenocarcinoma (LAPC) in combination with FOLFIRINOX or gemcitabine + nab-paclitaxel (GNP) chemotherapies.
48. Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study.
49. A selective policy in follow-up for bowel cancer
50. Sociocultural Factors in the Use of Prenatal Care by Hmong Women, Minneapolis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.